Nathaniel Rosko is an Executive Medical Science Liaison at Bristol Myers Squibb, specializing in multiple myeloma and lymphoma. He is an oncology pharmacist by training and spent the early part of his career at Cleveland Clinic, where he specialized in multiple myeloma and amyloidosis, rounded with lymphoma and myeloma inpatient services, and cared for patients in the outpatient Plasma Cell Disorders Clinic. Through these roles, he worked closely with multidisciplinary hematology teams and gained extensive experience managing patients with plasma cell malignancies across both inpatient and outpatient settings. Nathaniel joined Bristol Myers Squibb six years ago and now focuses on advancing the
